GLP-1 Market
LLY $1279.14 ▲ +0.4% NVO $39.13 ▲ +0.2% PFE $29.79 ▼ -0.8% VKTX $24.21 ▼ -0.8% KLRA $12.77 ▼ -0.6% GPCR $21.10 ▼ -0.4% RHHBY $59.98 ▼ -1.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Modafinil

Company
Kenneth Myers, MD
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
8 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

8 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 27, 2026

Find a Clinical Trial Near Me

See recruiting studies for Modafinil and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05333250

    Modafinil to Improve Fatiguability

    Not yet reported, Not yet reported Ottawa Hospital Research Institute 40 participants Est. completion 2028-03 1 site Stand-alone
    Other conditions: Cancer-related Cognitive Difficulties, Cancer-related Problem/Condition, Fatigue
    View official trial listing →
  • Recruiting NCT NCT05536011

    WAKIX® (Pitolisant) Pregnancy Registry

    Harmony Biosciences Management, Inc. 1329 participants Est. completion 2030-06-30 1 site
    Other conditions: Pregnancy Related, Narcolepsy
    View official trial listing →
  • Recruiting NCT NCT06041048

    Investigation of Locus Coeruleus Function in Sustained Attention

    Not yet reported University of California, Davis 40 participants Est. completion 2026-12-19 1 site
    Other conditions: Attention - no Condition is Being Assessed - Healthy Adults
    View official trial listing →
  • Recruiting NCT NCT06592352

    MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

    Not yet reported Clinical Academic Center (2CA-Braga) 64 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT07231497

    Cognitive Strategies in Early Psychosis 1

    Not yet reported University of Minnesota 103 participants Est. completion 2030-04-30 1 site Stand-alone
    Other conditions: Cognition, Healthy Participants
    View official trial listing →
  • Recruiting NCT NCT07263022

    Cognitive Strategies in Early Psychosis 2

    Not yet reported University of Minnesota 24 participants Est. completion 2030-04-30 1 site Stand-alone
    Other conditions: Psychosis, Schizophrenia Disorder, Schizoaffective Disorder, Major Depressive Disorder With Psychotic Features, Bipolar Disorder With Psychotic Features, Psychosis NOS, Schizophreniform Disorder, Psychotic Disorder, Cognition
    View official trial listing →
  • Recruiting NCT NCT07582458

    Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)

    Not yet reported, Not yet reported Radboud University Medical Center 60 participants Est. completion 2027-06 2 sites
    Other conditions: Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Chronic Fatigue
    View official trial listing →
  • Recruiting NCT NCT07830056

    Modafinil to Optimize the Performance of Cold-Stressed Sleep-Deprived Personnel

    Not yet reported United States Army Research Institute of Environmental Medicine 33 participants Est. completion 2026-12 1 site
    Other conditions: Sleep Deprivation, Cold Exposure
    View official trial listing →
  • Status unknown NCT NCT00033046

    Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1

    Not yet reported National Institute on Drug Abuse (NIDA) 12 participants Est. completion 2002-04 1 site
    Other conditions: Cocaine-Related Disorders, Drug Administration Schedule, Infusions, Intravenous
    View official trial listing →
  • Completed NCT NCT00042848

    Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

    Not yet reported Gary Morrow 837 participants Est. completion 2007-10 35 sites
    Other conditions: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00052286

    Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 29 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue
    View official trial listing →
  • Completed NCT NCT00057707

    Effects of Modafinil on Brain Function in Patients With Schizophrenia

    Not yet reported National Institute of Mental Health (NIMH) 176 participants Est. completion 2017-06-16 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00066170

    Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

    Not yet reported Jazz Pharmaceuticals 231 participants Est. completion 2004-11 40 sites Stand-alone
    Other conditions: Narcolepsy
    View official trial listing →
  • Terminated NCT NCT00067496

    Modafinil to Treat Fatigue in Post-Polio Syndrome

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2006-08 1 site
    Other conditions: Postpoliomyelitis Syndrome
    View official trial listing →
  • Completed NCT NCT00078312

    Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

    Not yet reported Cephalon 328 participants Est. completion 2006-07 50 sites
    Obstructive sleep apnea Other conditions: Narcolepsy, Sleep Apnea, Obstructive, Shift-Work Sleep Disorder
    View official trial listing →
  • Completed NCT NCT00078325

    Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)

    Not yet reported Cephalon 395 participants Est. completion 2004-11
    Obstructive sleep apnea Other conditions: Hypopnea
    View official trial listing →
  • Completed NCT NCT00078377

    Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

    Not yet reported Cephalon 196 participants Est. completion 2005-01
    Other conditions: Narcolepsy
    View official trial listing →
  • Completed NCT NCT00079677

    Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome

    Not yet reported Cephalon 263 participants Est. completion 2004-10
    Obstructive sleep apnea Other conditions: Sleep Hypopnea
    View official trial listing →
  • Completed NCT NCT00080288

    Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD

    Not yet reported Cephalon 254 participants Est. completion 2004-12
    Other conditions: Excessive Sleepiness, Shift Work Sleep Disorder
    View official trial listing →
  • Completed NCT NCT00086281

    Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients

    Not yet reported Jazz Pharmaceuticals 60 participants Est. completion 2005-11 2 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00100100

    Modafinil for the Treatment of Cocaine Dependence - 1

    Not yet reported National Institute on Drug Abuse (NIDA) 210 participants Est. completion 2006-12 6 sites
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Terminated NCT NCT00102284

    Neuromodulation and Language Acquisition (Project Stage Ia)

    Not yet reported University Hospital Muenster 100 participants Est. completion 2005-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00107796

    Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

    Not yet reported Cephalon 140 participants Est. completion 2005-09 73 sites
    Other conditions: Narcolepsy
    View official trial listing →
  • Completed NCT NCT00107809

    Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

    Not yet reported Cephalon 140 participants Est. completion 2005-09 64 sites
    Other conditions: Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT00107848

    PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

    Not yet reported Cephalon 280 participants Est. completion 2005-09 61 sites
    Other conditions: Narcolepsy, Sleep Apnea, Obstructive
    View official trial listing →
  • Status unknown NCT NCT00112515

    Modafinil in Treating Fatigue in Patients With Cancer

    Not yet reported University of Virginia 1 site
    Other conditions: Cognitive/Functional Effects, Depression, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00118378

    Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS

    Not yet reported New York State Psychiatric Institute 115 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: HIV Infections, Fatigue
    View official trial listing →
  • Status unknown NCT NCT00123370

    Trial of Modafinil for Methamphetamine Dependence

    Not yet reported The University of New South Wales 87 participants Est. completion 2007-09 2 sites
    Other conditions: Amphetamine Dependence
    View official trial listing →
  • Status unknown NCT NCT00123383

    Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

    Not yet reported The University of New South Wales 10 participants Est. completion 2007-09 2 sites
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00124384

    The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia

    Not yet reported University of Rochester 40 participants Est. completion 2007-08 1 site
    Other conditions: Primary Insomnia
    View official trial listing →
  • Completed NCT NCT00129285

    Modafinil Treatment for Cocaine-Dependent Individuals

    Not yet reported University of Pennsylvania 210 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00142402

    Modafinil in Multiple Sclerosis

    Not yet reported Kessler Foundation 20 participants Est. completion 2006-09 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00142818

    Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence

    Not yet reported Kyle Kampman 164 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Alcohol-Related Disorders, Alcoholism, Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00174174

    Provigil (Modafinil) Study by Taiwan Biotech Co.

    Not yet reported National Taiwan University Hospital 30 participants
    Other conditions: Narcolepsy, Cataplexy, Sleep Disorders, Hypersomnolence, Excessive Sleepiness
    View official trial listing →
  • Completed NCT NCT00178373

    Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

    Not yet reported University of Rochester 96 participants Est. completion 2006-03 1 site Stand-alone
    Other conditions: Cancer, Fatigue, Chemotherapy
    View official trial listing →
  • Completed NCT NCT00208715

    Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

    Not yet reported Emory University 100 participants Est. completion 2004-10 4 sites
    Other conditions: Major Depression, Mental Health
    View official trial listing →
  • Status unknown NCT NCT00210301

    Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

    Not yet reported Institute for Clinical Research 60 participants 1 site
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00214968

    Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness

    Not yet reported Cephalon 92 participants Est. completion 2005-10 Stand-alone
    Other conditions: Narcolepsy
    View official trial listing →
  • Completed NCT NCT00214981

    Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

    Not yet reported Cephalon Est. completion 2006-09 57 sites
    Other conditions: Attention Deficit/Hyperactivity Disorder, ADHD
    View official trial listing →
  • Completed NCT NCT00215176

    Modafinil for Atypical Depression

    Not yet reported, Not yet reported Duke University 65 participants Est. completion 2005-04
    Other conditions: Atypical Depression
    View official trial listing →
  • Completed NCT NCT00218023

    Medications for Stopping Cocaine Dependence and Preventing Relapse

    Not yet reported The University of Texas Health Science Center, Houston 101 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Cocaine Abuse, Cocaine-Related Disorders
    View official trial listing →
  • Terminated NCT NCT00218036

    Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

    Not yet reported The University of Texas Health Science Center, Houston 54 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Cocaine Abuse, Opiate Dependence
    View official trial listing →
  • Completed NCT NCT00218062

    Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals

    Not yet reported The University of Texas Health Science Center, Houston 73 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00218387

    Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1

    Not yet reported Medical University of South Carolina 123 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Status unknown NCT NCT00220506

    Fatigue Treatment Using Provigil

    Not yet reported Sheba Medical Center 50 participants Est. completion 2006-12 1 site
    Other conditions: All Multiple Sclerosis Patients
    View official trial listing →
  • Completed NCT NCT00223691

    Treatment of Orthostatic Hypotension in Autonomic Failure

    Not yet reported Vanderbilt University 389 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Autonomic Failure, Orthostatic Hypotension
    View official trial listing →
  • Completed NCT NCT00228540

    Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

    Not yet reported Cephalon Est. completion 2006-09 39 sites
    Other conditions: ADHD
    View official trial listing →
  • Completed NCT NCT00228566

    Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

    Not yet reported Cephalon 247 participants Est. completion 2006-07 43 sites
    Obstructive sleep apnea Other conditions: Excessive Daytime Sleepiness, Narcolepsy
    View official trial listing →
  • Terminated NCT NCT00233090

    Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment

    Not yet reported Icahn School of Medicine at Mount Sinai 21 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT00236080

    Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

    Not yet reported Cephalon 136 participants Est. completion 2005-12 20 sites
    Other conditions: Chronic Shift Work Sleep Disorder
    View official trial listing →
  • Completed NCT NCT00258479

    Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents

    Not yet reported Catherine Martin, MD 24 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Tobacco Use Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT00262470

    Treatment of Orthostatic Intolerance

    Not yet reported, Not yet reported Satish R. Raj 150 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Tachycardia, Chronic Orthostatic Intolerance
    View official trial listing →
  • Status unknown NCT NCT00265278

    Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

    Not yet reported National Institute on Drug Abuse (NIDA) 16 participants Est. completion 2006-03 1 site
    Other conditions: Amphetamine-Related Disorders
    View official trial listing →
  • Terminated NCT NCT00267332

    Modafinil in Opioid Induced Sedation

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 90 participants Est. completion 2006-12 1 site
    Other conditions: Cancer, Pain
    View official trial listing →
  • Terminated NCT NCT00297284

    Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil

    Not yet reported Hospital for Special Surgery, New York 20 participants Est. completion 2007-02 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00305292

    Modafinil-Alcohol Interactions in Healthy Volunteers

    Not yet reported University of California, San Francisco 32 participants Est. completion 2006-08 1 site
    Other conditions: Alcohol
    View official trial listing →
  • Completed NCT NCT00314639

    Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

    Not yet reported, Not yet reported Laval University 30 participants 1 site
    Other conditions: Schizophrenia and Schizophrenia Spectrum Psychosis
    View official trial listing →
  • Completed NCT NCT00315276

    Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

    Not yet reported Cephalon 370 participants Est. completion 2007-01 18 sites
    Other conditions: Attention Deficit Hyperactivity Disorder, ADHD
    View official trial listing →
  • Completed NCT NCT00343811

    Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

    Not yet reported Cephalon 120 participants Est. completion 2006-09 23 sites
    Other conditions: Attention Deficit Hyperactivity Disorder
    View official trial listing →
  • Completed NCT NCT00344565

    A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence

    Not yet reported Research Foundation for Mental Hygiene, Inc. 15 participants Est. completion 2007-03
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00368290

    Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior

    Not yet reported Kyle Kampman 94 participants Est. completion 2013-01 Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00373672

    Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Northwestern University 58 participants Est. completion 2010-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Withdrawn NCT NCT00393562

    Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease

    Not yet reported US Department of Veterans Affairs Est. completion 2007-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Suspended NCT NCT00396734

    The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.

    Not yet reported Hadassah Medical Organization 40 participants Est. completion 2011-04 1 site
    Other conditions: Opioid-Related Disorders, Cocaine-Related Disorders
    View official trial listing →
  • Terminated NCT NCT00418691

    Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

    Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2009-11 1 site
    Other conditions: Brain Tumor
    View official trial listing →
  • Completed NCT NCT00423943

    Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia

    Not yet reported University of California, Los Angeles 33 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00424931

    A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy

    Not yet reported Alza Corporation, DE, USA 16 participants Est. completion 2007-12 16 sites
    Other conditions: Narcolepsy
    View official trial listing →
  • Status unknown NCT NCT00439049

    Substance Abuse Pre-Treatment Screening Study

    The University of Texas Health Science Center, Houston 7500 participants Est. completion 2026-06 1 site
    Alcohol use disorder Other conditions: Cocaine Abuse, Cocaine Dependence, Opiate Dependence, Substance Abuse
    View official trial listing →
  • Completed NCT NCT00469508

    Modafinil vs Placebo for the Treatment of Methamphetamine Dependence

    Not yet reported University of California, Los Angeles 71 participants Est. completion 2009-01 1 site
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Completed NCT NCT00481195

    Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

    Not yet reported Cephalon 257 participants Est. completion 2008-12 55 sites
    Other conditions: Bipolar I Depression
    View official trial listing →
  • Completed NCT NCT00487942

    Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits

    Not yet reported Cephalon 60 participants Est. completion 2007-12 12 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00489892

    Efficacy of Pharmacological Treatment of Working Memory Impairment After Traumatic Brain Injury: Evaluation With fMRI

    Not yet reported Kessler Foundation 20 participants Est. completion 2008-12 1 site
    Other conditions: Traumatic Brain Injury, Severe Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00518986

    Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

    Not yet reported Cephalon 249 participants Est. completion 2009-03 62 sites
    Obstructive sleep apnea Other conditions: Sleep Disorders, Major Depressive Disorder, Dysthymic Disorder
    View official trial listing →
  • Completed NCT NCT00520286

    Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

    Not yet reported National Institute on Drug Abuse (NIDA) 210 participants Est. completion 2010-03 8 sites
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Completed NCT NCT00538655

    A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence

    Not yet reported California Pacific Medical Center Research Institute 20 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Methamphetamine Addiction
    View official trial listing →
  • Completed NCT NCT00546403

    Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia

    Not yet reported Veterans Medical Research Foundation 26 participants Est. completion 2008-02 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00555347

    Use of Armodafinil for Fatigue in Sarcoidosis

    Not yet reported, Not yet reported University of Cincinnati 20 participants Est. completion 2011-08 1 site
    Other conditions: Sarcoidosis, Fatigue, Sleepiness
    View official trial listing →
  • Completed NCT NCT00569374

    Safety and Tolerability of Modafinil for Methamphetamine Dependence

    Not yet reported University of Arkansas 8 participants 1 site
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Completed NCT NCT00573417

    A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia

    Not yet reported North Suffolk Mental Health Association 40 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00582491

    Modafinil, Sleep, and Cognition in Cocaine Dependence

    Not yet reported Yale University 44 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Cocaine Dependence, Substance-induced Sleep Disorder, Substance-induced Cognitive Disorder
    View official trial listing →
  • Terminated NCT NCT00591019

    Use of Modafinil in the Treatment of Tinnitus

    Not yet reported University of Arkansas 7 participants Est. completion 2008-06 1 site
    Other conditions: Tinnitus
    View official trial listing →
  • Completed NCT NCT00592943

    PET Study Examining the Dopaminergic Activity of Armodafinil in Adults

    Not yet reported, Not yet reported Massachusetts General Hospital 12 participants Est. completion 2010-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00613015

    Stress and Medication Effects on Cocaine Cue Reactivity

    Not yet reported Medical University of South Carolina 109 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Cocaine Related Disorders
    View official trial listing →
  • Completed NCT NCT00614926

    Modafinil for Treatment of Fatigue in ALS Patients

    Not yet reported New York State Psychiatric Institute 32 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Fatigue
    View official trial listing →
  • Terminated NCT NCT00620659

    Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)

    Not yet reported Merck Sharp & Dohme LLC 125 participants Est. completion 2009-02 Stand-alone
    Other conditions: Sleep Apnea, Obstructive, Hypopnea Syndrome, Excessive Daytime Sleepiness
    View official trial listing →
  • Terminated NCT NCT00626210

    Modafinil Treatment for Sleep/Wake Disturbances in Older Adults

    Not yet reported VA Palo Alto Health Care System 2 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Insomnia, Sleep Initiation and Maintenance Disorders, Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT00630097

    A Dose Ranging Study of Modafinil for Methamphetamine Dependence

    Not yet reported California Pacific Medical Center Research Institute 90 participants Est. completion 2011-06 1 site
    Other conditions: Substance Dependence, Amphetamine Dependence
    View official trial listing →
  • Completed NCT NCT00636896

    Effects of Modafinil on Olanzapine Weight Gain

    Not yet reported Neuropsychiatric Research Institute, Fargo, North Dakota 50 participants Est. completion 2007-08 1 site Stand-alone
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00650000

    Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

    Not yet reported Mylan Pharmaceuticals Inc 32 participants Est. completion 2002-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00650286

    Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

    Not yet reported Mylan Pharmaceuticals Inc 20 participants Est. completion 2002-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00670813

    Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil

    Not yet reported Technical University of Munich 30 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT00678691

    An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue

    Not yet reported State University of New York - Upstate Medical University 55 participants Est. completion 2009-12 1 site
    Other conditions: Fibromyalgia, Primary
    View official trial listing →
  • Completed NCT NCT00701532

    Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction

    Not yet reported Assistance Publique - Hôpitaux de Paris 29 participants Est. completion 2013-01 2 sites Stand-alone
    Other conditions: Cocaine Addiction, Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00702637

    Study of Modafinil to Treat Fatigue in Persons With Traumatic Brain Injury

    Not yet reported Craig Hospital 60 participants Est. completion 2005-03
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT00711464

    Modafinil Effects on Cognition in Schizophrenia Patients

    Not yet reported University of California, Los Angeles 29 participants Est. completion 2012-07 2 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00711516

    Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

    Not yet reported Cephalon 40 participants Est. completion 2009-10 9 sites
    Other conditions: Excessive Sleepiness
    View official trial listing →
  • Completed NCT NCT00737204

    Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS

    Not yet reported New York State Psychiatric Institute 70 participants Est. completion 2010-09 1 site
    Other conditions: HIV Infections, Fatigue
    View official trial listing →
  • Completed NCT NCT00751023

    Effects of Modafinil in Methamphetamine Dependence

    Not yet reported Medical University of South Carolina 40 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Completed NCT NCT00758498

    Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

    Not yet reported Cephalon 427 participants Est. completion 2009-02 4 sites
    Other conditions: Excessive Sleepiness
    View official trial listing →
  • Completed NCT NCT00766467

    A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

    Not yet reported Eudocia Quant Lee, MD 81 participants Est. completion 2014-07 4 sites
    Other conditions: Malignant Glioma
    View official trial listing →
  • Completed NCT NCT00772005

    Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

    Not yet reported Cephalon 287 participants Est. completion 2010-05 39 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00825227

    Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

    Not yet reported Cephalon 10 participants Est. completion 2010-02 29 sites
    Other conditions: Fatigue, Chemotherapy Side Effects
    View official trial listing →
  • Completed NCT NCT00829322

    Modafinil for the Treatment of Fatigue in Lung Cancer V9.0

    Not yet reported University of Oxford 208 participants Est. completion 2012-05 24 sites Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Withdrawn NCT NCT00838227

    Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

    Not yet reported Manhattan Psychiatric Center Est. completion 2012-06 Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00838981

    Pharmacotherapy & CM for Opioid and Cocaine Dependence

    Not yet reported, Not yet reported Yale University 91 participants Est. completion 2014-03 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00842985

    Dronabinol Interactions With Cognitive Enhancing Drug in Humans

    Not yet reported Yale University 53 participants Est. completion 2009-10 1 site
    Other conditions: Cannabis, Marijuana Abuse
    View official trial listing →
  • Terminated NCT NCT00859573

    Modafinil for Methamphetamine Dependence

    Not yet reported University of Arkansas 9 participants Est. completion 2010-01 1 site
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Terminated NCT NCT00893789

    Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

    Not yet reported Cephalon, Inc. 117 participants Est. completion 2011-01-31 73 sites
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00895570

    The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction

    Not yet reported Brigham and Women's Hospital 20 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Sleep Restriction, Impaired Glucose Metabolism
    View official trial listing →
  • Completed NCT NCT00916253

    Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies

    Not yet reported University Hospital, Bordeaux 27 participants Est. completion 2012-08 2 sites Stand-alone
    Other conditions: Narcolepsy, Hypersomnia
    View official trial listing →
  • Completed NCT NCT00917748

    Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)

    Not yet reported Sanofi 84 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Prostatic Neoplasms, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00943176

    Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)

    Not yet reported Mayo Clinic 40 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Fatigue, Primary Biliary Cirrhosis
    View official trial listing →
  • Completed NCT NCT00972985

    Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test

    Not yet reported Orasi Medical, Inc. 15 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00981084

    Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)

    Not yet reported, Not yet reported University of Missouri, Kansas City 33 participants Est. completion 2011-04 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT00983437

    Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

    Not yet reported Cephalon, Inc. 49 participants Est. completion 2011-01-31 61 sites
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT01010789

    Armodafinil in Binge Eating Disorder (BED)

    Not yet reported Lindner Center of HOPE 60 participants Est. completion 2015-05 1 site
    Other conditions: Binge Eating Disorder, Overweight, Obese
    View official trial listing →
  • Completed NCT NCT01011218

    Management of Insomnia in Breast Cancer Patients

    Not yet reported Stanford University 70 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Insomnia, Fatigue
    View official trial listing →
  • Completed NCT NCT01019187

    Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

    Not yet reported Abramson Cancer Center at Penn Medicine 226 participants Est. completion 2015-08 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01023672

    "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"

    Not yet reported Mayo Clinic 20 participants Est. completion 2012-03 1 site
    Other conditions: Dementia With Lewy Bodies
    View official trial listing →
  • Completed NCT NCT01032200

    Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

    Not yet reported Wake Forest University Health Sciences 54 participants Est. completion 2013-01-08 1 site
    Other conditions: Brain Tumors, Nervous System Tumors, Cognition Disorders, Fatigue
    View official trial listing →
  • Withdrawn NCT NCT01044004

    Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

    Not yet reported Washington University School of Medicine Est. completion 2012-06
    Other conditions: B-cell Lymphoma, Fatigue
    View official trial listing →
  • Withdrawn NCT NCT01048983

    Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

    Not yet reported, Not yet reported M.D. Anderson Cancer Center
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01067222

    Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

    Not yet reported Bioprojet 110 participants Est. completion 2010-12 1 site
    Other conditions: Narcolepsy, Excessive Daytime Sleepiness, Cataplexy, Sleep Disorders
    View official trial listing →
  • Completed NCT NCT01067235

    Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

    Not yet reported Bioprojet 14 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Narcolepsy, Cataplexy, Excessive Daytime Sleepiness
    View official trial listing →
  • Completed NCT NCT01072630

    Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

    Not yet reported Cephalon 492 participants Est. completion 2012-11 92 sites
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT01072929

    A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

    Not yet reported Cephalon 433 participants Est. completion 2012-03 40 sites
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT01080807

    Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

    Not yet reported Cephalon 385 participants Est. completion 2010-10 63 sites
    Other conditions: Excessive Sleepiness
    View official trial listing →
  • Completed NCT NCT01085903

    Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia

    Not yet reported University of Arkansas 28 participants Est. completion 2015-08 2 sites
    Other conditions: Spatial Neglect, Dysphagia
    View official trial listing →
  • Completed NCT NCT01091974

    Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

    Not yet reported University of Rochester 138 participants Est. completion 2013-04 2 sites
    Other conditions: Insomnia, Fatigue, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01092780

    Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)

    Not yet reported Merck Sharp & Dohme LLC 56 participants Est. completion 2011-05-31 Stand-alone
    Other conditions: Apnea, Sleep
    View official trial listing →
  • Completed NCT NCT01096680

    Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

    Not yet reported Shire 135 participants Est. completion 2010-07-18 1 site
    Other conditions: Sleep Deprivation
    View official trial listing →
  • Terminated NCT NCT01121536

    Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

    Not yet reported Cephalon 867 participants Est. completion 2013-10-31 158 sites
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT01137396

    Modafinil, Sleep Architecture and Cocaine Relapse

    Not yet reported Yale University 114 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT01160380

    A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

    Not yet reported Oncotherapeutics 50 participants Est. completion 2014-05 3 sites
    Other conditions: Fatigue, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01169753

    Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2013-02 1 site
    Other conditions: Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01172145

    Treatment of Apathy in Alzheimer's Disease With Modafinil

    Not yet reported Brown University 22 participants Est. completion 2007-09 1 site Stand-alone
    Other conditions: Apathy, Alzheimer's Disease
    View official trial listing →
  • Terminated NCT NCT01219673

    Symptom Burden in Head and Neck Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2014-01 1 site
    Other conditions: Head And Neck Cancer
    View official trial listing →
  • Withdrawn NCT NCT01256905

    Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

    Not yet reported NYU Langone Health Est. completion 2011-08-08 1 site
    Other conditions: Parkinsons Disease, Lewy Bodies Disease
    View official trial listing →
  • Completed NCT NCT01305408

    Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

    Not yet reported Cephalon 399 participants Est. completion 2013-07 130 sites
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT01317550

    A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil

    Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2016-02 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01330446

    Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 26 participants Est. completion 2022-12-08 2 sites
    Other conditions: Head And Neck Cancer, Fatigue
    View official trial listing →
  • Terminated NCT NCT01348607

    Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

    Not yet reported University of South Florida 1 participants Est. completion 2012-12 Stand-alone
    Other conditions: Central Nervous System Tumor, Pediatric, Fatigue, Specific Disorders of Sleep
    View official trial listing →
  • Completed NCT NCT01354470

    A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence

    Not yet reported California Pacific Medical Center Research Institute 72 participants 2 sites Stand-alone
    Other conditions: Methamphetamine Dependence
    View official trial listing →
  • Completed NCT NCT01365897

    Effectiveness of Modafinil in Improving Cognitive Performance of University Students

    Not yet reported Universidad de Valparaiso 128 participants Est. completion 2011-01 2 sites Stand-alone
    Other conditions: Attention, Memory, Short-Term, Executive Function
    View official trial listing →
  • Completed NCT NCT01381718

    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor

    Not yet reported University of South Florida 112 participants Est. completion 2016-08 60 sites Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Terminated NCT NCT01400958

    Nuvigil or Placebo in Newly Diagnosed Malignant Glioma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 6 participants Est. completion 2013-09 1 site
    Other conditions: Malignant Glioma
    View official trial listing →
  • Completed NCT NCT01440621

    Modafinil in Cancer Related Fatigue

    Not yet reported Indira Gandhi Medical College, Shimla 217 participants Est. completion 2012-02 1 site
    Other conditions: Cancer Related Fatigue, Quality of Life
    View official trial listing →
  • Completed NCT NCT01460628

    Effect of Nuvigil on Fatigue

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2013-12 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT01461174

    Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers

    Not yet reported Qualissima 36 participants Est. completion 2014-11 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01470651

    Armodafinil for Patients Starting Hepatitis C Virus Treatment

    Not yet reported Research Foundation for Mental Hygiene, Inc. 26 participants Est. completion 2014-06 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01601730

    Modafinil - Escitalopram Study for Cocaine Dependence

    Not yet reported Baylor College of Medicine 68 participants Est. completion 2011-07 1 site
    Other conditions: Cocaine Dependence, Cocaine Abuse, Cocaine Addiction, Substance Abuse
    View official trial listing →
  • Completed NCT NCT01624480

    Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 40 participants Est. completion 2015-12 24 sites
    Other conditions: Narcolepsy
    View official trial listing →
  • Completed NCT NCT01638403

    Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

    Not yet reported Bioprojet 180 participants Est. completion 2012-07 1 site
    Other conditions: Treatment of Excessive Daytime Sleepiness in Narcolepsy
    View official trial listing →
  • Completed NCT NCT01684306

    Pharmacological Cognitive Enhancement

    Not yet reported Università degli Studi 'G. d'Annunzio' Chieti e Pescara 26 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Fluid Inteligence, Modafinil, Healthy Young Subjects, Resting State Networks
    View official trial listing →
  • Status unknown NCT NCT01726088

    Modafinil in the Treatment of PTSD (Posttraumatic Stress Disorder)

    Not yet reported, Not yet reported Biomedical Research Foundation 40 participants Est. completion 2014-05 1 site
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT01746043

    A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer

    Not yet reported M.D. Anderson Cancer Center 22 participants Est. completion 2017-01 1 site
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Status unknown NCT NCT01766323

    Palliative Morphine With or Without Concurrent Modafinil

    Not yet reported Dr. Rajendra Prasad Government Medical College 200 participants Est. completion 2013-08 1 site
    Other conditions: Cancer, Pain Palliation, Excessive Sleepiness
    View official trial listing →
  • Completed NCT NCT01778010

    Modafinil for Smoked Cocaine Self-Administration

    Not yet reported New York State Psychiatric Institute 8 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT01781468

    Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

    Not yet reported Alliance for Clinical Trials in Oncology 328 participants Est. completion 2019-12-15 365 sites
    Other conditions: Fatigue
    View official trial listing →
  • Terminated NCT NCT01792583

    The Nuvigil and Provigil Pregnancy Registry

    Cephalon, Inc. 191 participants Est. completion 2023-11-30 1 site
    Obstructive sleep apnea Other conditions: Narcolepsy, Shift Work Sleep Disorder
    View official trial listing →
  • Terminated NCT NCT01800097

    Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent

    Not yet reported Herlev Hospital 41 participants Est. completion 2015-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01834547

    Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players

    Not yet reported K. Lieb 40 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Cognitively Healthy Subjects Influenced by Psychoactive Drugs
    View official trial listing →
  • Completed NCT NCT01896128

    Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke

    Not yet reported Burke Rehabilitation Hospital 19 participants Est. completion 2015-07 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Accident, Hemiparesis
    View official trial listing →
  • Completed NCT NCT01903824

    Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 40 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Cognitive Impairment
    View official trial listing →
  • Terminated NCT NCT01913327

    Antipsychotic Effects on Brain Function in Schizophrenia

    Not yet reported University of California, San Francisco 4 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT01951508

    Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study

    Not yet reported University Hospital, Basel, Switzerland 24 participants Est. completion 2014-12 1 site
    Other conditions: Healthy, Substance-related Disorder, Mood Disorder
    View official trial listing →
  • Completed NCT NCT01965925

    Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

    Not yet reported Icahn School of Medicine at Mount Sinai 18 participants Est. completion 2017-11-09 1 site Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT01988883

    Modafinil and Cognitive Function in POTS

    Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Postural Tachycardia Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02028260

    Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill

    Not yet reported Brigham and Women's Hospital Est. completion 2015-10 2 sites
    Other conditions: Delirium, Respiratory Failure
    View official trial listing →
  • Completed NCT NCT02051153

    Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 64 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Cognitive Performance, Creativity, Motivation, Reward, Healthy Volunteers, Subjective Pleasure
    View official trial listing →
  • Completed NCT NCT02071615

    Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers

    Not yet reported Charite University, Berlin, Germany 48 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02151253

    Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia

    Not yet reported, Not yet reported Duke University 81 participants Est. completion 2015-09 1 site
    Other conditions: Nocturia, Daytime Sleepiness
    View official trial listing →
  • Completed NCT NCT02155257

    Pain Expectations in Subjects With Osteoarthritis

    Not yet reported Wake Forest University Health Sciences 30 participants Est. completion 2017-10 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02222441

    Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)

    Not yet reported Pfizer 14 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02376257

    Improving Therapeutic Learning in Depression: Proof of Concept

    Not yet reported Boston University Charles River Campus 36 participants Est. completion 2017-05 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT02385656

    The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study

    Not yet reported Seoul National University Bundang Hospital 20 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT02468856

    Effect of Armodafinil on Simulated Driving

    Not yet reported University of Florida 12 participants Est. completion 2017-11-30 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02478580

    Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients

    Not yet reported University of Texas Southwestern Medical Center 67 participants Est. completion 2016-01 1 site
    Other conditions: Obesity, Premature Recovery From Anesthesia
    View official trial listing →
  • Terminated NCT NCT02494102

    Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea

    Not yet reported Milton S. Hershey Medical Center 105 participants Est. completion 2018-04-01 1 site
    Obstructive sleep apnea Other conditions: Delayed Emergence From Anesthesia
    View official trial listing →
  • Completed NCT NCT02538744

    Complementary Combination Therapy for Cocaine Dependence

    Not yet reported Baylor College of Medicine 45 participants Est. completion 2018-08-21 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT02552303

    The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia

    Not yet reported University of Pennsylvania 39 participants Est. completion 2015-07
    Other conditions: Sleep Apnea, Insomnia
    View official trial listing →
  • Completed NCT NCT02603861

    A Study of LY3154207 on Sleep in Healthy Male Participants

    Not yet reported Eli Lilly and Company 16 participants Est. completion 2016-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02696512

    A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

    Not yet reported, Not yet reported International Brain Research Foundation 30 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Brain Injury
    View official trial listing →
  • Completed NCT NCT02821715

    Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

    Not yet reported Theranexus 51 participants Est. completion 2019-02 8 sites Stand-alone
    Other conditions: Narcolepsy
    View official trial listing →
  • Completed NCT NCT02855229

    Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains

    Mclean Hospital 222 participants Est. completion 2021-08-31 1 site
    Other conditions: Translational Electrophysiology
    View official trial listing →
  • Withdrawn NCT NCT02857244

    A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients

    Not yet reported University of Chicago Est. completion 2017-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02896712

    Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention

    Not yet reported The University of Texas Health Science Center, Houston 118 participants Est. completion 2021-09-13 1 site Stand-alone
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT03083132

    Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)

    Not yet reported University of Arkansas 21 participants Est. completion 2019-11-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03182413

    Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation

    Not yet reported Theranexus 20 participants Est. completion 2016-03 Stand-alone
    Other conditions: Sleep Deprivation
    View official trial listing →
  • Completed NCT NCT03185065

    Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis

    Not yet reported Johns Hopkins University 141 participants Est. completion 2019-11-21 2 sites Stand-alone
    Other conditions: Fatigue in Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT03424681

    Modafinil for the Treatment of Alcohol Use Disorders

    Not yet reported The Mind Research Network 12 participants Est. completion 2018-08-31 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Status unknown NCT NCT03426202

    The Effect of Modafinil on Affective and Cognitive Processing

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2020-07-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03469089

    Touchscreen-based Cognitive Tests in Healthy Volunteers

    Not yet reported University of Eastern Finland 16 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Cognitive Symptom, Schizophrenia
    View official trial listing →
  • Completed NCT NCT03522506

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

    Not yet reported Takeda 20 participants Est. completion 2018-11-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03616717

    Modafinil Effects on EEG Biomarkers of Reward and Motivation

    Not yet reported University of California, San Diego 23 participants Est. completion 2021-09-30 1 site
    Other conditions: Healthy Adults
    View official trial listing →
  • Terminated NCT NCT03620253

    Modafinil's Effects on Cognition in Remitted MDD

    Not yet reported Unity Health Toronto 9 participants Est. completion 2019-08-06 1 site Stand-alone
    Other conditions: Major Depressive Disorder, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03621761

    Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue

    Not yet reported University of Michigan 343 participants Est. completion 2021-11-30 2 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT03624920

    Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

    Not yet reported Theranexus 77 participants Est. completion 2020-02-24 34 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03772314

    Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

    Not yet reported Emory University 44 participants Est. completion 2023-05-04 1 site
    Other conditions: Idiopathic Hypersomnia, Narcolepsy Without Cataplexy
    View official trial listing →
  • Completed NCT NCT03864042

    Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

    Not yet reported Pfizer 56 participants Est. completion 2023-05-29 29 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Metastatic Melanoma
    View official trial listing →
  • Status unknown NCT NCT03893032

    Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

    Not yet reported United States Army Aeromedical Research Laboratory 80 participants Est. completion 2019-10 1 site Stand-alone
    Other conditions: Cognition
    View official trial listing →
  • Completed NCT NCT03914118

    Modafinil to Prevent Postoperative Cognitive Decline

    Not yet reported The Cooper Health System 137 participants Est. completion 2013-01-31
    Other conditions: Postoperative Cognitive Dysfunction
    View official trial listing →
  • Completed NCT NCT03961997

    Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants

    Not yet reported Pfizer 16 participants Est. completion 2019-12-09 1 site
    Other conditions: Adult, Drug Interactions, Healthy Volunteers, Humans
    View official trial listing →
  • Withdrawn NCT NCT04317001

    Treatment for Cognitive Impairment in Depression

    Not yet reported Stanford University Est. completion 2024-11-30
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT04751227

    Modafinil for Wakefulness in the Critical Care Units

    King Faisal Specialist Hospital & Research Center 8 participants Est. completion 2021-01-30 1 site
    Other conditions: Critical Illness, COVID-19, Cognitive Dysfunction
    View official trial listing →
  • Completed NCT NCT05066009

    Sleep/Wake State Assessment with Non-invasive Earbuds

    Not yet reported Emory University 8 participants Est. completion 2023-10-27 1 site Stand-alone
    Other conditions: Hypersomnolence
    View official trial listing →
  • Active, not recruiting NCT NCT05351541

    Psilocybin Therapy for Chronic Low Back Pain

    Not yet reported, Not yet reported Joshua Woolley, MD, PhD 30 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Chronic Low-back Pain
    View official trial listing →
  • Not yet recruiting NCT NCT05675098

    Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy

    Not yet reported Kuwait University 30 participants Est. completion 2027-02-01 1 site Stand-alone
    Other conditions: Neurodevelopmental Disorders, Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT05855187

    Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)

    Not yet reported Genuine Research Center, Egypt 30 participants Est. completion 2023-01-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT06354985

    Modafinil and Exercise for Post Stroke Fatigue

    Not yet reported University Health Network, Toronto 212 participants Est. completion 2027-09
    Cardiovascular disease Other conditions: Fatigue, Modafinil, Exercise
    View official trial listing →
  • Completed NCT NCT06404086

    RECOVER-SLEEP: Platform Protocol

    Not yet reported Duke University 830 participants Est. completion 2025-12-31 47 sites
    Other conditions: Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance
    View official trial listing →
  • Completed NCT NCT06404099

    RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)

    Not yet reported Duke University 361 participants Est. completion 2026-04-20 1 site
    Other conditions: Long COVID, Long COVID-19, Hypersomnia
    View official trial listing →
  • Completed NCT NCT06619665

    A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

    Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2024-07-16 2 sites Stand-alone
    Other conditions: Healthy, Narcolepsy
    View official trial listing →
  • Completed NCT NCT06665230

    A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2023-11-20 1 site Stand-alone
    Other conditions: Healthy, Narcolepsy
    View official trial listing →
  • Completed NCT NCT07128719

    Study Effects of Preoperative Modafinil on Recovery Profile of Morbidly Obese Patients Scheduled for Bariatric Surgery if it Can Enhance Recovery From Anesthesia

    Not yet reported Ain Shams University 20 participants Est. completion 2025-06-01 1 site
    Other conditions: Obese Adolescents, Bariatric Surgery
    View official trial listing →
  • Not yet recruiting NCT NCT07295834

    Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial

    Not yet reported Imperial College London 70 participants Est. completion 2028-02-01 4 sites
    Other conditions: Crohn Disease (CD), Ulcerative Colitis (UC), Fatigue
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Completed NCT NCT07852130

    Reliability of Standardized IQ Testing Under Modafinil, Racetam-Class Compounds, Sleep Restriction and Daily Activity

    Not yet reported Abdulraheem Mohamed Gouda 70 participants Est. completion 2026-09-12 1 site Stand-alone
    Other conditions: Healthy, Cognition, Sleep Deprivation
    View official trial listing →
  • Not yet recruiting NCT NCT07887412

    Efficacy and Safety of Modafinil to Treat Fatigue in People With Mitochondrial Disease.

    Not yet reported Kenneth Myers, MD 15 participants Est. completion 2031-01-31 1 site Stand-alone
    Other conditions: Mitochondrial Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07895134

    Psilocybin for Depression in Veterans

    Not yet reported VA Office of Research and Development 150 participants Est. completion 2031-12-31 4 sites Stand-alone
    Other conditions: Major Depression
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Modafinil, Modafinil (M)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.